Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models.
Seetharam D, Chandar J, Ramsoomair CK, Desgraves JF, Alvarado Medina A, Hudson AJ, Amidei A, Castro JR, Govindarajan V, Wang S, Zhang Y, Sonabend AM, Mendez Valdez MJ, Maric D, Govindarajan V, Rivas SR, Lu VM, Tiwari R, Sharifi N, Thomas E, Alexander M, DeMarino C, Johnson K, De La Fuente MI, Alshiekh Nasany R, Noviello TMR, Ivan ME, Komotar RJ, Iavarone A, Nath A, Heiss J, Ceccarelli M, Chiappinelli KB, Figueroa ME, Bayik D, Shah AH.
Seetharam D, et al. Among authors: lu vm.
J Clin Invest. 2025 Mar 17;135(6):e183745. doi: 10.1172/JCI183745.
J Clin Invest. 2025.
PMID: 40091830
Free PMC article.